Skip to content

Clinical trials

Phase 3 Nervous System Diseases trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Phase: Phase 3 Country / region: Poland Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20131
20143
20151
20161
20173
20181
20191
20202
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
PTC Therapeutics3
AstraZeneca2
Auspex Pharmaceuticals, Inc.2
Ipsen2
Baxalta now part of Shire1
Eli Lilly and Company1
Emalex Biosciences Inc.1
Hoffmann-La Roche1
Quince Therapeutics S.p.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases19
Central Nervous System Diseases11
Brain Diseases9
Neurodegenerative Diseases9
Movement Disorders7
Mental Disorders5
Alzheimer Disease4
Dementia4
Genetic Diseases, Inborn4
Neuromuscular Diseases4

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.